hit counter
Aurinia Pharmaceuticals Inc. (AUPH) Stock News Sentiment & Price - Sentifly
AUPH - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Aurinia Pharmaceuticals Inc. (AUPH)

Canada
Biotechnology
NASDAQ
AUPH Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AUPH Latest news
The Motley Fool
Positive
2 Best Biotech Stocks to Buy Right Now
2021-09-25 07:00

Aurinia Pharmaceuticals and Axsome Therapeutics are two names that growth investors should have on their radars right now.

Zacks Investment Research
Positive
Implied Volatility Surging for Aurinia (AUPH) Stock Options
2021-09-20 10:43

Investors need to pay close attention to Aurinia (AUPH) stock based on the movements in the options market lately.

Business Wire
Neutral
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
2021-09-15 13:11

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the senior management team will present at the following upcoming virtual investor conferences: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Monday, September 20, 2021 at 2:55 pm ET. (access here) Cantor Global Healthcare Conference on September 30, 2021 at 12:40 pm ET. (access here) In order to participate in the audio webcasts, interested p

Business Wire
Neutral
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
2021-09-10 13:30

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the senior management team will participate in the H.C. Wainwright & Co. 23rd Annual Global Investment Conference, September 13-15, 2021. The Aurinia presentation will be available on-demand beginning September 13, 2021 at 3 pm ET. The audio webcast is available here. Interested parties can also register and access the presentation under "News/Events” thro

Zacks Investment Research
Positive
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options
2021-08-18 11:29

Investors need to pay close attention to Aurinia Pharmaceuticals (AUPH) stock based on the movements in the options market lately.

Zacks Investment Research
Positive
Aurinia (AUPH) Adds Two Candidates, Boosts Immunology Pipeline
2021-08-18 11:29

Aurinia (AUPH) acquires two pre-clinical, novel pipeline programs for the treatment of rare autoimmune, fibrotic and kidney diseases. Yet, the stock price declines.

Benzinga
Positive
Aurinia Adds Two Assets To Expand Its Immunology Pipeline
2021-08-17 06:39

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has added two assets to expand its rare autoimmune and kidney-related disease pipeline. The first program, AUR200, was acquired from privately-held Thunderbolt Pharma Inc.

Business Wire
Neutral
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases
2021-08-17 06:05

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced the addition of two novel assets that will expand the Company's rare autoimmune and kidney-related disease pipeline. “Over the past year, in anticipation of building out and diversifying our development pipeline, we have brought on additional large and small molecule expertise that uniquely aligns with Aurinia's focus on immunology and nephrology,” said Peter Greenle

Business Wire
Neutral
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference
2021-08-09 07:55

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the executive management team will participate in a fireside chat during the Virtual BTIG Annual Biotech Conference on Tuesday, August 10, 2021 at 2:50 p.m. ET. In order to participate in the audio webcast, interested parties can access the live webcast under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.co

The Motley Fool
Positive
Why Aurinia Pharmaceuticals Stock Was Surging on Friday
2021-08-06 13:54

Investors were relieved to see significant sales from the company's first commercial-stage drug.

Loading more news...